https://orcid.org/0000-0002-7701-8597
Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Vivek Chavda, Rajashri Bezbaruah, Tutumoni Kalita, Anupam Sarma, Juti Rani Devi, Ratnali Bania & Vasso Apostolopoulos. (2022) Variant influenza: connecting the missing dots. Expert Review of Anti-infective Therapy 20:12, pages 1567-1585.
Read now
Read now
Manish Dhawan, Abhilasha Sharma, Priyanka, Nanamika Thakur, Tridib Kumar Rajkhowa & Om Prakash Choudhary. (2022) Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Vivek P. Chavda, Yangmin Chen, Jayant Dave, Zhe-Sheng Chen, Subhash C. Chauhan, Murali M. Yallapu, Vladimir N. Uversky, Rajashri Bezbaruah, Sandip Patel & Vasso Apostolopoulos. (2022) COVID-19 and vaccination: myths vs science. Expert Review of Vaccines 21:11, pages 1603-1620.
Read now
Read now
Vivek P. Chavda, Lalitkumar K. Vora & Vasso Apostolopoulos. (2022) Monkeypox: a new face of outbreak. Expert Review of Vaccines 21:11, pages 1537-1540.
Read now
Read now
Vivek P. Chavda, Melina Haritopoulou-Sinanidou, Rajashri Bezbaruah & Vasso Apostolopoulos. (2022) Vaccination efforts for Buruli ulcer. Expert Review of Vaccines 21:10, pages 1419-1428.
Read now
Read now
Vivek P. Chavda, Aayushi B. Patel, Lalitkumar K. Vora, Vasso Apostolopoulos & Bruce D. Uhal. (2022) Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management. Expert Review of Vaccines 21:10, pages 1395-1403.
Read now
Read now
Vivek P Chavda, Riddhi Prajapati, Disha Lathigara, Bhumi Nagar, Jay Kukadiya, Elrashdy M Redwan, Vladimir N Uversky, Mukesh N Kher & Rajvi Patel. (2022) Therapeutic monoclonal antibodies for COVID-19 management: an update. Expert Opinion on Biological Therapy 22:6, pages 763-780.
Read now
Read now
Articles from other publishers (27)
Margherita Galli, Agnese Zardini, Worku Nigussa Gamshie, Stefano Santini, Ademe Tsegaye, Filippo Trentini, Valentina Marziano, Giorgio Guzzetta, Mattia Manica, Valeria d’Andrea, Giovanni Putoto, Fabio Manenti, Marco Ajelli, Piero Poletti & Stefano Merler. (2023) Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply. Scientific Reports 13:1.
Crossref
Crossref
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, Nirav Shah, Sachin Verma, Shrinivas Savale & Suma Ray. (2023) Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update. Process Biochemistry 127, pages 66-81.
Crossref
Crossref
Sibel Kalyoncu, Semiramis Yilmaz, Ayca Zeybek Kuyucu, Dogu Sayili, Olcay Mert, Hakan Soyturk, Seyda Gullu, Huseyin Akinturk, Erhan Citak, Merve Arslan, Melda Guray Taskinarda, Ibrahim Oguzhan Tarman, Gizem Yilmazer Altun, Ceren Ozer, Ridvan Orkut, Aysegul Demirtas, Idil Tilmensagir, Umur Keles, Ceren Ulker, Gizem Aralan, Yavuz Mercan, Muge Ozkan, Hasan Onur Caglar, Gizem Arik, Mehmet Can Ucar, Muzaffer Yildirim, Tugce Canavar Yildirim, Dilara Karadag, Erhan Bal, Aybike Erdogan, Serif Senturk, Serdar Uzar, Hakan Enul, Cumhur Adiay, Fahriye Sarac, Arzu Tas Ekiz, Irem Abaci, Ozge Aksoy, Hivda Ulbegi Polat, Saban Tekin, Stefan Dimitrov, Aykut Ozkul, Gerhard Wingender, Ihsan Gursel, Mehmet Ozturk & Mehmet Inan. (2023) Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris. Scientific Reports 13:1.
Crossref
Crossref
Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra, Ester Blanco, Grazyna Kochan & David Escors. (2023) mRNA Vaccines against SARS-CoV-2: Advantages and Caveats. International Journal of Molecular Sciences 24:6, pages 5944.
Crossref
Crossref
Vivek P. Chavda, Divya Teli, Pankti C. Balar, Dixa Vaghela, Hetvi K. Solanki, Akta Vaishnav & Lalitkumar Vora. (2023) Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population. Molecules 28:5, pages 2332.
Crossref
Crossref
Oscar Mamani-Benito, Rosa Farfán-Solís, Mariné Huayta-Meza, Madona Tito-Betancur, Wilter C. Morales-García & Edison Effer Apaza Tarqui. (2023) Effect of religious fatalism and concern about new variants on the acceptance of COVID-19 vaccines. Frontiers in Psychiatry 14.
Crossref
Crossref
Prashant Pokhriyal, Vivek P. Chavda & Mili Pathak. 2023. Bioinformatics Tools for Pharmaceutical Drug Product Development. Bioinformatics Tools for Pharmaceutical Drug Product Development
401
416
.
Rajashri Bezbaruah, Mainak Ghosh, Shuby Kumari, Lawandashisha Nongrang, Sheikh Rezzak Ali, Monali Lahiri, Hasmi Waris & Bibhuti Bhushan Kakoti. 2023. Bioinformatics Tools for Pharmaceutical Drug Product Development. Bioinformatics Tools for Pharmaceutical Drug Product Development
345
369
.
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, Bindra Patel, Anup Kumar, Sanjay Prasad, Bibhuti Bhusan Kakoti, Ajeet Kaushik & Mariya Jesawadawala. (2023) Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status. Vaccines 11:2, pages 432.
Crossref
Crossref
Vivek Chavda, Disha Valu, Palak Parikh, Nikita Tiwari, Abu Chhipa, Somanshi Shukla, Snehal Patel, Pankti Balar, Ana Paiva-Santos & Vandana Patravale. (2023) Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants. Vaccines 11:2, pages 374.
Crossref
Crossref
Vivek Chavda, Pankti Balar, Dixa Vaghela, Hetvi Solanki, Akta Vaishnav, Vivek Hala & Lalitkumar Vora. (2023) Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management. Vaccines 11:1, pages 160.
Crossref
Crossref
Vivek P. Chavda, Toshika Mishra & Suneetha Vuppu. (2022) Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2. Vaccines 11:1, pages 45.
Crossref
Crossref
Vivek Chavda, Feng-Feng Ping & Zhe-Sheng Chen. (2022) An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10:12, pages 2072.
Crossref
Crossref
Vivek P. Chavda, Aayushi B. Patel, Lalitkumar K. Vora, Rajeev K. Singla, Priyal Shah, Vladimir N. Uversky & Vasso Apostolopoulos. (2022) Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for
the Treatment of COVID-19. Current Pharmaceutical Design 28:46, pages 3658-3670.
Crossref
Crossref
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Aayushi B. Patel, Nikita Sharma & Zhe-Sheng Chen. (2022) Recent review of COVID-19 management: diagnosis, treatment and vaccination. Pharmacological Reports 74:6, pages 1120-1148.
Crossref
Crossref
Vivek Chavda, Rajashri Bezbaruah, Kangkan Deka, Lawandashisha Nongrang & Tutumoni Kalita. (2022) The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far. Vaccines 10:11, pages 1926.
Crossref
Crossref
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, Vasso Apostolopoulos, Chirag A. Patel, Rajashri Bezbaruah, Aayushi B. Patel & Zhe-Sheng Chen. (2022) Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world. Frontiers in Immunology 13.
Crossref
Crossref
Vivek P Chavda, Aayushi B Patel, Anjali Pandya, Lalitkumar K Vora, Vandana Patravale, Zara M Tambuwala, Alaa AA Aljabali, Ángel Serrano-Aroca, Vijay Mishra & Murtaza M Tambuwala. (2022) Co-infection associated with SARS-CoV-2 and their management. Future Science OA 8:9.
Crossref
Crossref
Vivek P. Chavda, Anup Kumar, Rittwika Banerjee & Nayan Das. (2022) Ayurvedic and Other Herbal Remedies for Dengue: An Update. Clinical Complementary Medicine and Pharmacology 2:3, pages 100024.
Crossref
Crossref
Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi & Pooja N. Dhamade. (2022) Pseudoscience and fraudulent products for COVID-19 management. Environmental Science and Pollution Research 29:42, pages 62887-62912.
Crossref
Crossref
Vivek P Chavda, Shailvi Soni, Riddhi Prajapati, Murali M Yallapu & Vasso Apostolopoulos. (2022)
Reply to the letter ‘
Effectiveness of COVID-19 vaccines against Omicron variant’
. Immunotherapy 14:12, pages 905-908.
Crossref
Crossref
Vivek P Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M Yallapu & Vasso Apostolopoulos. (2022) Therapeutics to tackle Omicron outbreak. Immunotherapy 14:11, pages 833-838.
Crossref
Crossref
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, Assunta Patano, Alberto Corriero, Luigi Vimercati, Daniela Azzollini, Grazia Marinelli, Giovanni Coloccia, Fabio Piras, Giuseppe Barile, Vito Settanni, Antonio Mancini, Nicole De Leonardis, Grazia Garofoli, Giulia Palmieri, Ciro Gargiulo Isacco, Biagio Rapone, Arnaldo Scardapane, Luigi Curatoli, Nicola Quaranta, Mario Ribezzi, Maria Massaro, Megan Jones, Ioana Roxana Bordea, Gianluca Martino Tartaglia, Antonio Scarano, Felice Lorusso, Luigi Macchia, Angela Maria Vittoria Larocca, Sergey Khachatur Aityan, Silvio Tafuri, Pasquale Stefanizzi, Giovanni Migliore, Nicola Brienza, Gianna Dipalma, Gianfranco Favia & Francesco Inchingolo. (2022) Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast. International Journal of Molecular Sciences 23:15, pages 8485.
Crossref
Crossref
Vivek P. Chavda, Mahesh T. Chhabria & Vasso Apostolopoulos. (2022) Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes. Biologics 2:3, pages 165-170.
Crossref
Crossref
Vivek P. Chavda, Aayushi B. Patel & Darsh D. Vaghasiya. (2022) SARS‐CoV‐2 variants and vulnerability at the global level. Journal of Medical Virology 94:7, pages 2986-3005.
Crossref
Crossref
Zoufang Huang, Vivek P. Chavda, Lalitkumar K. Vora, Normi Gajjar, Vasso Apostolopoulos, Nirav Shah & Zhe-Sheng Chen. (2022) 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update. Frontiers in Pharmacology 13.
Crossref
Crossref
Vivek P. Chavda, Rajashri Bezbaruah, Mansi Athalye, Palak K. Parikh, Abu Sufiyan Chhipa, Snehal Patel & Vasso Apostolopoulos. (2022) Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena. Viruses 14:4, pages 759.
Crossref
Crossref